Connect with us

Health

2021 Best Dr Lee Burnett of Student Doctor Network

Published

on

techydeed.com

techydeed.com

Lee, how did you come to initiate the Student Doctor Network (SDN)?

Back in 1994, I started a free national newspaper for osteopathic medical students. Simultaneously, the net was starting to gain notice, and the initial websites started to pop up — they were not over a single column of text, a few links, and a picture or two. Website programming was elementary, so I decided to take the posts we were printing and put them online. That assortment of online articles finally became “Osteopathic.com.”

Though Osteopathic.com was an early website, it was the 2nd medical student website online. The first was a site by Nancy Sween, a librarian in the University of Kansas School of Medicine. The third medical student site on the Web was “The big guide to medical college” from Jim Henderson, MD. We got together and decided to utilize one forum for all the websites. In 1999 we combined our websites and found under one domain, “studentdoctor.net.” Over time the site grew to include the majority of the other doctoral degree healthcare professions.

How did it grow? What were some of the significant milestones and turning points along the way?

The website has always had one focus — helping students get right into and throughout health professional college. We insist on providing open and unbiased resources at no (or very low) price. Students already spend enough on tuition, rent, food and textbooks.

Providing the site for free necessitates low overhead — all of our forum moderators are volunteers. The site did not break even for its first six decades, and I paid for the site expenses and maintained the servers myself until 2006. You will find many long nights fixing servers at the data centre.

However, I did not mind; SDN is something that I enjoy for our membership and fantastic volunteers. Without them, there is no SDN. Our members and volunteers are a few of the best on the world wide web, they’re helpful, provide great information, are often extremely funny and always inviting.

Advertisement

As a result of our great members and raised earnings from sponsorships and donations, by 2009, the site had grown enough to enhance and enlarge SDN by investing in specialist programming, design and I.T. management. It’s exciting to learn how SDN has increased through the years.

How is SDN run?

SDN is published by a 501(c)3 nonprofit educational organization. Our moderators are all volunteers. I serve as a volunteer director of the website. We have a couple of part-time staff that help manage our helpdesk, sponsors, and I.T. and project management.

What are your plans for the future of SDN?

Over the years, I had many ideas that SDN could not manage to develop and needed to be placed on the’to-do’ list. But now, a number of these are nearing conclusion.

Advertisement

We’re working to develop more funds to help students get right into and through the healthcare program of their choice. We want to provide additional support along their route.

We’ve got a few cool items coming this year, such as “How to Choose a Medical Specialty” which is debuting in Test Prep Week.

What and when is SDN’s Test Prep Week?

Test Prep Week is an annual event for our members to find out about all of the unique test-prep providers, products and publications. The event is free for both pupils and test-prep companies. The event was launched in 2007, and thanks to the hard work of one of our volunteer supervisors, Anna Peck, PharmD, it was an instant success, and it has grown each year. For 2013, it’s February 18-22.

Lee, I discovered on your LinkedIn profile that You’re a decorated officer and Brigade Surgeon in the U.S. Army. How can you come to select a career in the Army?

Although I owned my family clinic and appreciated my office and patients, I liked my time mobilized with the Army even more. In 2009 I decided to sell my practice and go full-time together with the Army. I’m happy I did; I have appreciated almost daily with the Army. My spouse has supported my transition into full-time Army support; I couldn’t do it.

Advertisement

However, I’d do it. Soldiers are some of the most dedicated, intelligent and amazing people. It is an honour to serve them.

When there was only one piece of advice you would like to give pre-healthcare pupils (other than the use of Student Doctor Network), what would it be?

Be sure you desire to be a physician for the proper reasons. Get decent advice along with a realistic picture by speaking with as many physicians in your desired field as you can. Please do not be shy about it. Most doctors are happy to share their experiences with students who are thinking about becoming doctors.

I have one additional recommendation if you have a chance to take a year off from faculty, take action. Travelling the world for your entire year and get as many adventures as possible. As soon as you start down the long road of being a doctor, you’ll end up coming from the other end in your early 30s, cross-eyed from analyzing, 15lbs fatter, and also a lot paler.

Lee, thank you very much for taking the time to answer these queries. It’s much appreciated.

Advertisement

Check it out. And check out SDN’s Exam Prep week, which begins Monday. We’ll be there.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published.

Health

WHO’s Solidarity trial in a new phase will test three potential COVID-19 medications

Published

on

By

WHO's Solidarity trial in a new phase will test three potential COVID-19 medications techydeed.com

The study started in June 2021 and will continue until May 2022. It is currently being done in more than 600 hospitals across 52 countries.

The second phase of the World Health Organization’s (WHO) Solidarity PLUS trial is now underway. It will be testing four new therapies – Artesunate, imatinib and infliximab – to treat COVID-19.

There were four drugs: remdesivir (hydroxychloroquine), lopinavir, interferon, and hydroxychloroquine. Evaluation of a previous Solidarity PLUS trial They found that they had little or no effect upon hospitalized patients void-19

An independent panel of experts selected these drugs because they could lower the death risk for patients in hospitals.COVID-19 These are the manufacturers of these. These are the manufactures Donations of medicines that were made. Thank you for participating in the trials.

Advertisement

Also Read: Quest and LabCorp offer COVID-19 Antibody Testing. But should you get one?

The World Health Organization’s Solidarity PLUS trial is the world’s largest ongoing randomized control trial of potential COVID-19 therapeutics. It is the largest international collaboration between the WHO Member States.

It allows the trial to simultaneously evaluate multiple treatments using the same protocols, thanks to the involvement of thousands of patients and researchers. They can also get solid estimates of the drug’s impact on mortality, even moderate ones.

The WHO adds new treatments to its guidelines while dropping ineffective, unsafe, or ineffective.

The study started in June 2021 and will continue until May 2022. The study is currently being carried out in more than 600 hospitals across 52 countries.

Advertisement

“Finding more effective and accessible therapeutics for COVID-19 patients remains a critical need, and WHO is proud to lead this global effort,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

These drugs include:

Also Read: Additional COVID vaccine approved by the US. for people with weak immunity

  • Ipca manufactures Artesunate It to treat malaria. It is made from the herb Artemisia Annua. Artemisinin is a derivative that Artesunate has been used for malaria treatment for more than 30 years. Artesunate can be considered very safe. Artemisia, also known as Sweet Wormwood, can be found in Asia and North America. The standard malaria treatment will be administered intravenously for seven consecutive days. Its anti-inflammatory properties and effectiveness will also be evaluated.
  • Imatinib Novartis produces it, and it is used as a cancer treatment. It’s an oral drug. Early experimental data suggest that it may “reverse the pulmonary capillary loss.” It is administered orally for 14 days daily.
  • Infliximab Johnson and Johnson have produced it and uses it to treat immune-system-related diseases. It is a TNFalpha inhibitor. This chimeric monoclonal antibody recognizes human TNFalpha. These anti-TNF medications have been used for over 20 years. They have been proven safe and effective in reducing inflammation across a broad spectrum, even in the elderly population who are clinically most vulnerable.COVID-19. The standard does Crohn’s Disease patients received intravenously will be administered.

Continue Reading

Health

For some reason, the official name of the Pfizer vaccine is Comirnaty

Published

on

By

For some reason, the official name of the Pfizer vaccine is Comirnaty techydeed.com

Spikevax and Comirnaty: The strange world of branding COVID-19 vaccinations

With official Food and Drug Administration approval, the Pfizer / BioNTech mRNA COVID-19 vaccine can now be marketed as Comirnaty in the US, great news for general vaccine acceptance, sure, but also anyone who loves to fixate on bizarre drug names.

Comirnaty appears to be a combination of multiple words: community, immunity COVID-19, and mRNA.Fierce Pharmacy writes. Pfizer-BioNTech was the one who designed the branding. Brand Institute —The #1 Naming Company in the World” — It is shorter than many drug names, and it doesn’t roll off the tongue as well.

It’s also not as strong as the original.SpikevaxThe European brand name for the Moderna vaccine and another Brand Institute project. SpikevaxDirectly refers to the complex structure of COVID-19, and the word “vaccines” (having “vax” in the name is big. I’ve seen). This could be a great second wind for US Moderna supporters. People who have lived under the shadow of the “hot person vaccine” once approved by the FDA. Vaxzevria is the European brand name for AstraZeneca’s vaccine. It’s a little more complicated. It is hard to find anything else to say except that they got vax there and are doing so immediately. Dr. Doom in your head whenever I can quickly read the name.

Advertisement

Although the names may be funny, the absurdity of the characters is evident because, except during a dark pandemic, when would anyone even notice the brand name for a vaccine? We are at the perfect intersection of enough time to care, enough worry to obsess, and enough nihilism for laughter. Remember this next year when new flu shot brand names drop. Afluria 2 is going to require your attention.

Continue Reading

Health

WHO and ISARIC collaborate to collect international data to understand ‘long COVID’ symptoms better

Published

on

By

WHO and ISARIC collaborate to collect international data to understand 'long COVID' symptoms better techydeed.com

The first phase, which will examine the outcomes to be measured, will be completed over the next few months. The second phase will be completed by 2022.

On Thursday, the coordinated international effort to collect standardised data about Long Covid marked a significant step in the quest to uncover the secrets behind Long Covid.

The World Health Organization announced a joint project with the International Severe Acute Respiratory & Emerging Infection Consortium to create a core outcome set (COS). This will help to build a better picture of post-Covid conditions.

ISARIC stated that Long Covid, one of the less understood parts of the pandemic, was an emerging global healthcare crisis.

Advertisement

We don’t know why some people struggle to recover after the acute phase of infection. They may experience ongoing shortness of breath and extreme fatigue, brain fog, and other neurological and cardiac disorders.

Despite a “significant portion” of COVID-19 cases going on to suffer from Long Covid, “the evidence for this condition is limited and based on small patient cohorts with short-term follow-up,” ISARIC said.

“A COS is urgently needed to standardise and optimise clinical data collection across studies (especially clinical trials) and clinical practice.

The statement stated that an international group of post-Covid and COS experts had created a research program alongside the WHO and ISARIC.

The Post-Covid Core Outcomes project will begin with a survey of Long Covid patients.

Advertisement

The first phase will be completed within the next few months to examine what outcomes should be measured. The second phase will be completed by 2022 and will address how to measure these outcomes.

Unknown number

According to a tally from official sources compiled by AFP, nearly 205 million coronavirus cases have been registered since the outbreak emerged in China in December 2019.

While the true number, which includes unrecorded cases of Long Covid, will be much higher, it is still unknown how many people are suffering from Long Covid.

Last week, the WHO stated that it was working with Long Covid sufferers to develop better rehabilitation programs.

This year, the organisation held a series of seminars to increase understanding of post-Covid conditions. They heard directly from sufferers as well as doctors and scientists.

Advertisement

Janet Diaz, WHO’s expert on Long Covid, stated that there were more than 200 symptoms last week.

Diaz stated that some patients experienced symptoms that continued beyond the acute phase. Others got better but then relapsed. Some had conditions that could come back or go. Other patients suffered symptoms that appeared only after the acute phase.

Some patients experience symptoms that last for up to nine months.

Advertisement
Continue Reading

Trending

Copyright © 2021 TechyDeed.

close